Enzolytics Financial Statements From 2010 to 2024
| ENZC Stock | USD 0.0009 0.0001 10.00% |
Check Enzolytics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enzolytics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Enzolytics financial statements analysis is a perfect complement when working with Enzolytics Valuation or Volatility modules.
Enzolytics |
Enzolytics Company Shares Outstanding Analysis
Enzolytics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Enzolytics Shares Outstanding | 2.44 B |
Most of Enzolytics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Enzolytics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Enzolytics has 2.44 B of shares currently outstending. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The shares outstanding for all United States stocks is significantly lower than that of the firm.
Enzolytics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Enzolytics's current stock value. Our valuation model uses many indicators to compare Enzolytics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Enzolytics competition to find correlations between indicators driving Enzolytics's intrinsic value. More Info.Enzolytics is one of the top stocks in return on asset category among its peers. It also is one of the top stocks in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Enzolytics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Enzolytics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Enzolytics Financial Statements
Enzolytics stakeholders use historical fundamental indicators, such as Enzolytics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Enzolytics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Enzolytics' assets and liabilities are reflected in the revenues and expenses on Enzolytics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Enzolytics. Please read more on our technical analysis and fundamental analysis pages.
Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. In addition, it has created a proprietary cell line that produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Enzolytics Pink Sheet
Enzolytics financial ratios help investors to determine whether Enzolytics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Enzolytics with respect to the benefits of owning Enzolytics security.